sensing the invisible

user-friendly, non-invasive and real-time optical monitoring device for preemptive detection of pressure injuries (PI)

*The picture is for illustration only,  final product design may vary.

IR-Med is developing

Pressure Safe

Early detection of pressure injuries

Nobotics

with a view to improving patients treatment and avoiding unnecessary consumption of Antibiotics by identifying the ear infection source - Bacteria or Viral

NIDM

(Non-Invasive Drug Monitor)

Real-time, noninvasive optical monitoring for determining Propofol blood concentration.

LATEST NEWS

April 8, 2021
IR-Med, Inc. Announces the Resignation of Limor Davidson Mund as CEO and Appointment of Chairman of the Board Oded Bashan as Interim Chief Executive Officer
January 20, 2021
IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to “IRME”
December 29, 2020
International Display Advertising, Inc. Announces Completion of Reverse Merger and Closing of $2.2 Million Private Placement
September 3, 2020
International Display Advertising, Inc and ir Med Ltd Agree to Securities Exchange Agreement

OUR VISION

IR-MED vision is to become the gold standard of detection and monitoring of preventable or incipient medical conditions through developing revolutionary non invasive, high usability medical devices based on the combination of Infra-Red (IR) and Artificial Intelligence (AI) technologies.

*The picture is for illustration only,  final product design may vary.

Unmet Need: Early Detection of Pressure Injuries

PI represent a substantial financial burden for global healthcare systems

UNITED STATES PI​

2.5M

PATIENTS PER YEAR

26.8B​​

TOTAL COST OF ACUTE CARE ATTRIBUTABLE TO HOSPITAL

70K​​

PATIENTS DEATH
42% - PATIENTS IN ICUS
28% - HOSPICE PATIENTS​

4.1 - 32.2​

Prevalence in
long-term care